Current Development of Metal Complexes with Diamine Ligands as Potential Anticancer Agents

Area of Science:

• Medicinal Chemistry
• Inorganic Chemistry
• Cancer Research

Background:

• Dinitrogen-containing moieties are crucial for the anticancer action of metal complexes, as exemplified by cisplatin.
• Diamine ligands themselves can exhibit cytotoxicity, contributing to the overall efficacy of metal complexes.

Purpose of the Study:

• To review the anticancer efficacy, selectivity, and mechanisms of action of metal complexes featuring diverse diamine ligands.
• To compare the activity and toxicity of these complexes against their organic ligands alone and platinum-based chemotherapeutics.

Main Methods:

• Analysis of aliphatic acyclic, aliphatic cyclic, and aromatic diamine ligands in metal complexes.
• Comparison of metal complexes with varying metal ions (e.g., Pt, Ru, Au, Pd, Ir) and oxidation states.
• Evaluation of ligand lipophilicity and its impact on cellular uptake.

Main Results:

• Aliphatic acyclic diamines are predominantly found in platinum complexes; aliphatic cyclic and aromatic diamines appear in complexes with multiple metal ions.
• Ligand lipophilicity influences cellular uptake, with specific ligands like ethylenediamine-N,N'-diacetic acid (edda) and its derivatives showing utility.
• Aliphatic cyclic diamines enhance the activity/toxicity profile of oxaliplatin-type complexes, while aromatic diamine complex mechanisms remain largely uninvestigated.
• Investigated complexes primarily induce apoptotic or necrotic cell death.

Conclusions:

• Metal complexes incorporating diamine ligands represent promising, potentially more selective alternatives to conventional platinum-based chemotherapy.
• Further investigation into the physicochemical properties and molecular mechanisms is essential for developing these complexes as therapeutic agents.